Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
5.50
+0.06 (1.10%)
At close: Jul 22, 2025, 4:00 PM
5.61
+0.11 (2.00%)
After-hours: Jul 22, 2025, 4:04 PM EDT

Vivos Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts that cover Vivos Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $6.1, which forecasts a 10.91% increase in the stock price over the next year. The lowest target is $6 and the highest is $6.2.

Price Target: $6.1 (+10.91%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$6.00$6.10$6.20$6.20
Change+9.09%+10.91%+12.73%+12.73%
* Price targets were last updated on Apr 15, 2025.

Analyst Ratings

The average analyst rating for Vivos Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy222222
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$6.6$6.2
Strong BuyMaintains$6.6$6.2+12.73%Apr 15, 2025
Ascendiant Capital
Ascendiant Capital
Strong Buy
Reiterates
$6.6
Strong BuyReiterates$6.6+20.00%Nov 20, 2024
Alliance Global Partners
Alliance Global Partners
Strong Buy
Maintains
$8.25$6
Strong BuyMaintains$8.25$6+9.09%Nov 19, 2024
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$6.4$6.6
Strong BuyMaintains$6.4$6.6+20.00%Aug 20, 2024
Ascendiant Capital
Ascendiant Capital
Strong Buy
Initiates
$63
Strong BuyInitiates$63+1,036.36%Jan 17, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
15.61M
from 15.03M
Increased by 3.83%
Revenue Next Year
19.55M
from 15.61M
Increased by 25.27%
EPS This Year
-1.57
from -2.22
EPS Next Year
-0.95
from -1.57
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
13.07M16.89M16.02M13.80M15.03M15.61M19.55M
Revenue Growth
14.68%29.23%-5.10%-13.87%8.91%3.83%25.27%
EPS
-34.94-23.89-25.90-11.14-2.22-1.57-0.95
EPS Growth
-------
Forward PE
-------
No. Analysts
-----44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026
High17.4M20.2M
Avg15.6M19.5M
Low13.7M18.7M

Revenue Growth

Revenue Growth20252026
High
16.0%
29.4%
Avg
3.8%
25.3%
Low
-8.7%
19.9%

EPS Forecast

EPS20252026
High-1.62-0.74
Avg-1.57-0.95
Low-1.51-1.14

EPS Growth

EPS Growth20252026
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.